A 6-week window provides two extra weeks for the BPC-157 to establish a micro-vascular network before the peptide stimulus is removed
Preclinical Gastrointestinal Prokinetic Efficacy and Endocrine Effects of the Ghrelin Mimetic RM-131
BPC-157 targets exactly the weakness that makes tendons and ligaments so slow to heal, the blood supply problem, and the preclinical research supporting that idea is strong and consistent
Regulation of IGF binding protein-1 in hep G2 cells by cytokines and reactive oxygen species
The following are known triggers of mast cell degranulation (in addition to IgG activation via pathogen or allergen):[ref] Acetylcholine Complement fragments (C3, C4, C5) Various drugs, environmental toxins (MRGPRX2 receptor, details below) Peptides (including endorphin, leptin, PTH, and more) Physical conditions (cold, heat, pressure, stress, and vibration)